Syndax Pharmaceuticals
SNDX
SNDX
163 hedge funds and large institutions have $1.54B invested in Syndax Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 74 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $1.78B → $1.54B (-$243M)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
44% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $3.49M
Holders
163
Holding in Top 10
8
Calls
$1.97M
Puts
$3.49M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$14.6M | |
| 3 | +$13.6M | |
| 4 |
EP
Eversept Partners
New York
|
+$12.4M |
| 5 |
BlackRock
New York
|
+$11.6M |
Top Sellers
| 1 | -$42.1M | |
| 2 | -$20.7M | |
| 3 | -$12.7M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$9.42M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$8.91M |